Medexus Pharmaceuticals Inc.
OTC: MEDXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Kenneth d'Entremont
- Employees
- 82
- Headquarters
- Bolton, Canada
- IPO year
- 2017
- Market cap
- $94.3M
- Website
- https://www.medexus.com
Loading MEDXF…
Loading profile data…Frequently asked questions about MEDXF
What does Medexus Pharmaceuticals Inc. (MEDXF) do?
Medexus Pharmaceuticals Inc. is a specialized pharmaceutical firm conducting operations across both Canada and the United States. The company's therapeutic focus spans several critical domains, including cancer treatment (oncology), blood disorders (hematology), joint and muscle conditions (rheumatology), autoimmune disorders, and allergic react...
Where does MEDXF trade?
Medexus Pharmaceuticals Inc. (MEDXF) trades on the Other OTC.
What sector is MEDXF in?
Medexus Pharmaceuticals Inc. (MEDXF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Medexus Pharmaceuticals Inc.?
Kenneth d'Entremont is the chief executive officer of Medexus Pharmaceuticals Inc. (MEDXF).
Where is Medexus Pharmaceuticals Inc. headquartered?
Medexus Pharmaceuticals Inc. is headquartered in Canada.
Does MEDXF pay a dividend?
Medexus Pharmaceuticals Inc. (MEDXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MEDXF go public?
Medexus Pharmaceuticals Inc. (MEDXF) completed its initial public offering in 2017.